Pfizer’s $5B Obesity Bet Sparks Legal Battle With Novo Nordisk
Pfizer has filed a lawsuit against Novo Nordisk and Metsera over a competing $9 billion bid for the obesity drug developer. The legal battle reveals the escalating war for obesity treatment dominance as pharmaceutical giants scramble for market position.